Search
for
Sort by
Research 121–150 of 1000+
- WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Skin and hair: models for exploring organ regeneration
- An Intrinsic Oscillation of Gene Networks Inside Hair Follicle Stem Cells: An Additional Layer That Can Modulate Hair Stem Cell Activities
- The concealed side of caspases: beyond a killer of cells
- Epigenetic regulations on skin wound healing: implications from current researches.
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Alopecia Areata: Current Review
- Mesenchymal–epithelial interactions during hair follicle morphogenesis and cycling
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- Spatiotemporal dynamics of mammalian wound healing
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Smoothened receptor inhibitor vismodegib for the treatment of basal cell carcinoma: a retrospective analysis of efficacy and side effects
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- STAT3 Partly Inhibits Cell Proliferation via Direct Negative Regulation of FST Gene Expression
- Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review